TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.

Kosj YamoahPriti LalShivanshu AwasthiArash O NaghaviRobert J RounbehlerTravis GerkeAnders E BerglundJulio M Pow-SangEdward M SchaefferJasreman DhillonJong Y ParkTimothy R Rebbeck

Published in: The Prostate (2020)

ERGnegative tumor status is the strongest predictor of anterior prostate tumors, regardless of race. Furthermore, AR expression and canonical AR signaling do not impact tumor location.

Keyphrases

prostate cancer
poor prognosis
radical prostatectomy
binding protein
long non coding rna